D-galactose Supplementation for the Treatment of Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE): A Pilot Trial of Precision Medicine After Epilepsy Surgery-Reference-Cited by-同舟云学术

D-galactose Supplementation for the Treatment of Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE): A Pilot Trial of Precision Medicine After Epilepsy Surgery

Published:2023-09 Issue:5 Volume:20 Page:1294-1304
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Aledo-Serrano Ángel^ORCID,Valls-Carbó Adrián,Fenger Christina D.,Groeppel Gudrun,Hartlieb Till,Pascual Irene,Herraez Erika,Cabal Borja,García-Morales Irene,Toledano Rafael,Budke Marcelo,Beltran-Corbellini Álvaro,Baldassari Sara,Coras Roland,Kobow Katja,Herrera David M.,del Barrio Antonio,Dahl Hans Atli,del Pino Isabel,Baulac Stéphanie,Blumcke Ingmar,Møller Rikke S.,Gil-Nagel Antonio

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-023-01395-z.pdf

Reference47 articles.

1. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update;Hauptman;Epilepsia,2012

3. Clinical features, neuropathology, and surgical outcome in patients with refractory epilepsy and brain somatic variants in the SLC35A2 gene;Barba;Neurology,2023

4. Clinical characteristics and postoperative seizure outcome in patients with mild malformation of cortical development and oligodendroglial hyperplasia;Gaballa;Epilepsia,2021